Welcome to #1 DIGITAL HEALTH NEWS Portal

Open Call DIGITAL-2021-DEPLOY-01-TWINS-HEALTH: An Ecosystem for Digital Twins in Healthcare

The development of digital twins in healthcare (DTH) has progressed substantially, profiting from advances in science and technology. In order to exploit their benefits in view of better prevention approaches, faster and more accurate diagnoses, personalised treatments and care, a framework to structure cooperation and leverage on synergies between academia, private sector, regulators and end-users needs to be strengthened.

Read more ...

Mayo Clinic Researchers Use AI, Biomarkers to Personalize Rheumatoid Arthritis Treatment

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence (AI) and pharmacogenomics to predict how patients will respond to treatments, and to personalize care. Findings were published in Arthritis Care & Research.

Read more ...

Computer Model of Blood Enzyme

Membrane-associated proteins play a vital role in a variety of cellular processes, yet little is known about the membrane-association mechanism. Lipoprotein-associated phospholipase A2 (Lp-PLA2) is one such protein with an important role in cardiovascular health, but its mechanism of action on the phospholipid membrane was unknown.

Read more ...

AI Points the Way to Better Doctor-Patient Communication

A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand. The study also uncovered strategies some doctors use to overcome communication barriers.

Read more ...

Could EKGs Help Doctors use AI to Detect Pulmonary Embolisms?

Pulmonary embolisms are dangerous, lung-clogging blot clots. In a pilot study, scientists at the Icahn School of Medicine at Mount Sinai showed for the first time that artificial intelligence (AI) algorithms can detect signs of these clots in electrocardiograms (EKGs), a finding which may one day help doctors with screening.

Read more ...

Computer Programs and Mobile Apps may Help Meet the Growing Demand for Mental Healthcare

The COVID-19 pandemic has had a major impact on mental health across the globe. Depression is predicted to be the leading cause of lost life years due to illness by 2030. At the same time, less than 1 in 5 people receive appropriate treatment.

Digital interventions - which package up psychotherapeutic components into a computer program or mobile app - have been proposed as a way of meeting the unmet demand for psychological treatment.

Read more ...

Philips and IJsselland Hospital Sign Long-Term Technology Partnership

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has signed a 12-year strategic partnership with IJsselland Hospital (Capelle aan den Ijssel, The Netherlands). As the hospital's strategic technology partner, Philips will target improved care for patients and care providers at IJsselland Hospital and in the surrounding region.

Read more ...

Oracle Buys Cerner

Oracle Corporation (NYSE: ORCL) and Cerner Corporation jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities.

Read more ...

Study Finds AI Accurately Detects Fractures on X-Ray

Emergency room and urgent care clinics are typically busy and patients often have to wait many hours before they can be seen, evaluated and receive treatment. Waiting for x-rays to be interpreted by radiologists can contribute to this long wait time because radiologists often read x-rays for a large number of patients.

Read more ...

Start of the European FAST III Study: Angio-Derived Assessment of Blood Flow in Diseased Coronary Arteries

The first patients were recently enrolled in the FAST III trial at the Erasmus University Medical Center in Rotterdam, The Netherlands. This officially marked the beginning of a multicenter, randomized-controlled, open-label study in which the outcome of therapy for coronary artery disease is being investigated after fractional flow reserve (FFR) has been determined using different methods.

Read more ...